Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (20)

2021

  1. Inhibition of the NLRP3 inflammasome prevents ovarian aging

    Science Advances, Vol. 7, Núm. 1

2020

  1. Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer

    Redox Biology, Vol. 36

  2. NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 75, Núm. 8, pp. 1457-1464

  3. Sequential Changes of NLRP3 Inflammasome Activation in Sepsis and its Relationship With Death

    Shock (Augusta, Ga.), Vol. 54, Núm. 3, pp. 294-300

2018

  1. Intracellular cholesterol accumulation and coenzyme Q10 deficiency in Familial Hypercholesterolemia

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 12, pp. 3697-3713

2017

  1. NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction

    Oncotarget, Vol. 8, Núm. 59, pp. 99740-99756

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Mutation in cytochrome b gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activation

    Journal of Medical Genetics, Vol. 53, Núm. 2, pp. 113-122

  4. Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implications

    Clinical Rheumatology, Vol. 35, Núm. 10, pp. 2565-2571

  5. Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome

    Molecular Neurobiology, Vol. 53, Núm. 7, pp. 4874-4882

2015

  1. Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 11, pp. 2535-2553

  2. Pharmacological chaperones and coenzyme Q10 treatment improves mutant β-glucocerebrosidase activity and mitochondrial function in neuronopathic forms of gaucher disease

    Scientific Reports, Vol. 5

2013

  1. Apoptotic microtubules delimit an active caspase free area in the cellular cortex during the execution phase of apoptosis

    Cell Death and Disease, Vol. 4, Núm. 3

2012

  1. Recovery of MERRF Fibroblasts and Cybrids Pathophysiology by Coenzyme Q10

    Neurotherapeutics, Vol. 9, Núm. 2, pp. 446-463

  2. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease

    British Journal of Pharmacology, Vol. 167, Núm. 6, pp. 1311-1328

2011

  1. Secondary coenzyme Q 10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts

    FASEB Journal, Vol. 25, Núm. 8, pp. 2669-2687

2010

  1. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: Implications in the pathogenesis of the disease

    Arthritis Research and Therapy, Vol. 12, Núm. 1

2009

  1. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy

    Autophagy, Vol. 5, Núm. 1, pp. 19-32

  2. Coenzyme Q10 distribution in blood is altered in patients with Fibromyalgia

    Clinical Biochemistry, Vol. 42, Núm. 7-8, pp. 732-735